Parkinson’s disease (PD) is traditionally regarded as a neurodegenerative movement disorder, however, nigrostriatal dopaminergic degeneration is also thought to disrupt non-motor loops connecting basal ganglia to areas in frontal cortex involved in cognition and emotion processing. PD patients are impaired on tests of emotion recognition, but it is difficult to disentangle this deficit from the more general cognitive dysfunction that frequently accompanies disease progression. Testing for emotion recognition deficits early in the disease course, prior to cognitive decline, better assesses the sensitivity of these non-motor corticobasal ganglia-thalamocortical loops involved in emotion processing to early degenerative change in basal ganglia circuits. In addition, contrasting this with a group of healthy aging individuals demonstrates changes in emotion processing specific to the degeneration of basal ganglia circuitry in PD. Early PD patients (EPD) were recruited from a randomized clinical trial testing the safety and tolerability of deep brain stimulation (DBS) of the subthalamic nucleus (STN-DBS) in early-staged PD. EPD patients were previously randomized to receive optimal drug therapy only (ODT), or drug therapy plus STN-DBS (ODT + DBS). Matched healthy elderly controls (HEC) and young controls (HYC) also participated in this study. Participants completed two control tasks and three emotion recognition tests that varied in stimulus domain. EPD patients were impaired on all emotion recognition tasks compared to HEC. Neither therapy type (ODT or ODT + DBS) nor therapy state (ON/OFF) altered emotion recognition performance in this study. Finally, HEC were impaired on vocal emotion recognition relative to HYC, suggesting a decline related to healthy aging. This study supports the existence of impaired emotion recognition early in the PD course, implicating an early disruption of fronto-striatal loops mediating emotional function.
Emotion recognition is an important aspect of social interaction. Deficits in emotion recognitionhave been tied to poor social competence, interpersonal functioning, and communication along with a reduced quality of life and inappropriate social behavior. Recent experimental evidence suggests that emotion recognition ability across modalities seems to change in an age-dependent way, with deficits specifically noted for negative emotion recognition. Therefore, the primary purpose of this study is to assess emotion recognition ability in both the visual and auditory modalities in healthy elderly patients versus healthy young patients to test the hypothesis that deficits in emotion recognition ability are age-related and increase with age across visual and auditory modalities. The secondary purpose of this study is to assess valence-specific emotion recognition ability to test the hypothesis that increased deficits for elderly individuals as compared to young healthy subjects occur for negative emotion recognition specifically. We examined the ability to recognize emotion in the auditory and visual modality in two groups of patients: healthy elderly subjects and healthy young subjects. The Montreal Affective Voices task (MAV), the Distorted Tunes task (DTT), the Awareness of Social Inference test (TASIT), and the BaronCohen Mind in the Eyes Test (EYES) were used to gauge emotion recognition ability. For the visual tasks (TASIT and EYES), the elderly subjects and young subjects did not have significant differences in performance. In addition, a significant difference was also not found for the DTT, indicating that both populations had intact lower-level auditory processing abilities. Significant differences were found between the two populations on the MAV task in both baseline accuracy and valence-specific performance. These findings suggest that age-related deficits in emotion recognition may be specific to the recognition of auditory emotion.
Guillain-Barré syndrome (GBS) is an inflammatory polyneuropathy that classically presents with low back pain, sensory paresthesias, and rapidly progressive weakness. Patients with GBS can develop dysautonomia, and Takotsubo cardiomyopathy (TCM) is a rare potential manifestation of this dysautonomia. This association has been reported only 12 times in the literature so far, which we review here. We present two cases of GBS associated with TCM, to increase awareness with regard to this comorbid relationship, which would encourage prompt initiation of proper supportive care to avoid morbidity and mortality.We report the case of two patients -a 58-year-old man and a 79-year-old woman -who developed TCM in the setting of axonal variants of GBS. Electrodiagnostic results, cerebrospinal fluid profiles, and echocardiogram findings were consistent with these diagnoses. Both patients were treated with intravenous immunoglobulin (IVIG) in an intensive care unit (ICU) setting. Echocardiogram findings were reversible.TCM should be recognized as a potential complication of GBS in patients with dysautonomia. This case series adds to the sparse body of literature describing the association between these two conditions. It is not clear if patients with axonal variants of GBS are more predisposed to developing TCM; further, larger case series in the future may help identify the risk factors associated with it. We hope to shed more light on this possible association to expedite the diagnosis and management of this condition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.